Page results
-
UCLH is to trial a COVID-19 vaccine developed by Imperial College London.
-
Our Getting Ready for Transition (GReaT) to secondary school parent information session will run on Wednesday 29 January 2025.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
Scientists and academics from UCL and UCLH have informed a new set of clinical guidelines to aid better diagnosis and management of endometriosis.
-
Today is the 72 anniversary of the NHS – and it is dedicated to our amazing staff.
-
On Tuesday 22nd February 2022, the UCLH children and young people's diabetes team are holding a workshop, between 5-7pm on Zoom, for young people who are moving to adult services in 2022/2023, to share information about adult clinics.
-
UCLH and UCL researchers have set out how artificial intelligence (AI) can and should be harnessed to transform hearing healthcare and research.
-
The Carbs & Cals app is moving to a subscription-based service.
-
A UCLH patient with a rare hormonal condition is the first in the world to receive a new investigational drug in a first-in-human trial.
-
How UCLH staff have helped to develop a new exhibition at the Science Museum, called Cancer Revolution: Science, Innovation and Hope.
File results
-
FOI/2023/0072 - Contact centre
-
FOI/2023/0073 - Telephony and UC/ collaboration, Microsoft 365 licence and on-premise or cloud storage
-
FOI/2023/0078 - Total loss written off in 2021/22
-
FOI/2023/0088 - Appointments changed from in person to telephone due to industrial action
-
FOI/2021/0284 - Sleep respiratory service
-
FOI/2023/0099 - Number of autoclaves used at Trust
-
FOI/2023/0101 - Trauma protocols in pregnant patients
-
FOI/2023/0103 - Genetic Haemochromatosis patients
-
FOI/2023/0117 - EPRR Team contact information
-
FOI/2023/0125 - Staffing rota/ planning to support working parents